Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis

NCT02387853 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02387853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02387853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2016
Completion date
March 28, 2018
Enrollment
117 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris